Company
Atlas Venture
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| Kinaset Therapeutics | Series B | 2026-01-12 | |
| Triana Biomedicines | Series B | 2025-12-03 | |
| Affinia Therapeutics | Series C | 2025-10-08 | |
| Antares Therapeutics | Series A | 2025-06-11 | Lead |
| Vima Therapeutics | Series A | 2025-05-30 | Lead |
| Be Bio | Series C | 2025-01-15 | |
| nChroma Bio | Financing | 2024-12-12 | Lead |
| Be Bio | Funding | 2024-10-23 | |
| Judo Bio | Series A | 2024-10-07 | Lead |
| Kailera Therapeutics | Series A Funding | 2024-10-01 | Lead |
| Scorpion Therapeutics | Series C Financing | 2024-07-16 | Lead |
| Diagonal Therapeutics | Financing | 2024-04-04 | Lead |
| Sionna Therapeutics | Series C Financing | 2024-03-07 | |
| Accent Therapeutics | Series C | 2024-01-23 | |
| Triveni Bio | Series A | 2023-10-26 | Lead |
| Aiolos Bio | Series A Funding | 2023-10-25 | Lead |
| Chroma Medicine | Series B Financing | 2023-03-01 | |
| Matchpoint Therapeutics | Series A | 2022-10-17 |